A detailed history of All Square Wealth Management LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, All Square Wealth Management LLC holds 769 shares of NTLA stock, worth $7,936. This represents 0.01% of its overall portfolio holdings.

Number of Shares
769
Previous 769 -0.0%
Holding current value
$7,936
Previous $17,000 11.76%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 27, 2023

SELL
$31.62 - $45.78 $34,782 - $50,358
-1,100 Reduced 58.86%
769 $24,000
Q2 2021

Aug 13, 2021

SELL
$60.88 - $161.91 $14,002 - $37,239
-230 Reduced 10.96%
1,869 $303,000
Q1 2021

May 11, 2021

BUY
$46.59 - $83.68 $1,537 - $2,761
33 Added 1.6%
2,099 $168,000
Q4 2020

Feb 09, 2021

BUY
$18.83 - $63.53 $3,464 - $11,689
184 Added 9.78%
2,066 $112,000
Q3 2020

Nov 16, 2020

SELL
$17.47 - $24.93 $4,332 - $6,182
-248 Reduced 11.64%
1,882 $37,000
Q2 2020

Aug 11, 2020

BUY
$11.14 - $22.87 $11,674 - $23,967
1,048 Added 96.86%
2,130 $45,000
Q3 2019

Nov 06, 2019

BUY
$13.07 - $18.51 $1,176 - $1,665
90 Added 9.07%
1,082 $14,000
Q1 2019

May 07, 2019

BUY
$12.79 - $17.62 $11,191 - $15,417
875 Added 747.86%
992 $17,000
Q3 2018

Nov 02, 2018

SELL
$25.78 - $32.6 $1,495 - $1,890
-58 Reduced 33.14%
117 $3,000
Q1 2018

May 11, 2018

BUY
$19.43 - $34.95 $1,457 - $2,621
75 Added 75.0%
175 $4,000
Q4 2017

Feb 13, 2018

SELL
$17.39 - $31.12 $330 - $591
-19 Reduced 15.97%
100 $2,000
Q3 2017

Nov 06, 2017

BUY
$15.16 - $25.75 $1,804 - $3,064
119
119 $3,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $784M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track All Square Wealth Management LLC Portfolio

Follow All Square Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of All Square Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Square Wealth Management LLC with notifications on news.